Our group’s main focus is the development of bioactive molecules against serious human diseases such as fibrosis, cancer and autoimmune disorders. Towards that end, we use state-of-the-art Medicinal Chemistry approaches including the design, synthesis and pharmacological evaluation (in vitro and in vivo) of novel molecules endowed with new mechanisms of action. Our projects are multidisciplinary in nature and involve a seamless integration of:

• Synthesis of heterocyclic compounds

• Chemical Biology, Enzymology

• Molecular Pathophysiology and animal modeling (in collaboration with other labs)


B.S.R.C. "Alexander Fleming"
34 Fleming Street, 16672 Vari, Greece
Contact us - Privacy Policy